Borsini F, Nowakowska E, Samanin R
Life Sci. 1984 Mar 19;34(12):1171-6. doi: 10.1016/0024-3205(84)90089-4.
A 7-day treatment with 20 mg/kg/day desipramine reduced the immobility time in the behavioral "despair" test in rats. The effect of DMI was antagonized by sulpiride (100 mg/kg i.p.), metoclopramide (20 mg/kg i.p.) and clopazine (20 mg/kg i.p.) but not by haloperidol (0.5 mg/kg i.p.) or chlorpromazine (5 mg/kg i.p.). Alpha-adrenoreceptor blockers (prazosin 3 mg/kg s.c.; aceperone 10 mg/kg i.p.; azapetine 24 mg/kg s.c.; phentolamine 20 mg/kg i.p.), dl-propranolol (5 mg/kg i.p.) and clonidine (0.1 mg/kg i.p.) failed to modify the anti-immobility effect of DMI. The data suggest that a particular subtype of dopamine receptors is involved in the anti-immobility effect of a 7-day treatment with DMI in the behavioral "despair" test in rats.
每天以20毫克/千克的剂量给予地昔帕明进行为期7天的治疗,可减少大鼠行为“绝望”试验中的不动时间。舒必利(腹腔注射100毫克/千克)、甲氧氯普胺(腹腔注射20毫克/千克)和氯哌嗪(腹腔注射20毫克/千克)可拮抗地昔帕明的作用,但氟哌啶醇(腹腔注射0.5毫克/千克)或氯丙嗪(腹腔注射5毫克/千克)则不能。α-肾上腺素受体阻滞剂(皮下注射哌唑嗪3毫克/千克;腹腔注射阿塞哌隆10毫克/千克;皮下注射阿扎哌汀24毫克/千克;腹腔注射酚妥拉明20毫克/千克)、dl-普萘洛尔(腹腔注射5毫克/千克)和可乐定(腹腔注射0.1毫克/千克)未能改变地昔帕明的抗不动作用。数据表明,在大鼠行为“绝望”试验中,为期7天的地昔帕明治疗的抗不动作用涉及特定亚型的多巴胺受体。